TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...
The FDA has approved the first and only pill to prevent COVID-19 after exposure to the virus. Here's how it works. (Photo: ...
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
No. COVID-19 vaccines have not been linked to as many as 3.9 million deaths. Wisconsin U.S. Sen. Ron Johnson said on May 9, ...
As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...
FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...
The infant mortality rate in the United States rose for the first time in two decades between 2021 and 2022, but social media ...
COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...
Will Hantavirus cause the next pandemic? A public health expert explains why it is unlikely to result in a global pandemic, and discusses the U.S. response thus far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results